Pharmaids Pharmaceuticals Limited (BOM:524572)
India · Delayed Price · Currency is INR 36.12
+1.26 (3.61%)
At close: Mar 5, 2026
Pharmaids Pharmaceuticals Market Cap
Pharmaids Pharmaceuticals has a market cap or net worth of 1.27 billion as of March 5, 2026. Its market cap has decreased by -45.68% in one year.
Market Cap
1.27B
Enterprise Value
1.47B
Revenue
255.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
36.12
Market Cap Chart
Since January 11, 2002, Pharmaids Pharmaceuticals's market cap has increased from 12.26M to 1.27B, an increase of 10,290.65%. That is a compound annual growth rate of 21.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 1.27B | -24.21% |
| Dec 31, 2025 | 1.68B | -32.38% |
| Dec 31, 2024 | 2.49B | 137.65% |
| Dec 29, 2023 | 1.05B | 185.46% |
| Dec 26, 2022 | 366.41M | 131.65% |
| Dec 31, 2021 | 158.17M | -6.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 9, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Astonea Labs | 1.67B |
| Coral Laboratories | 1.53B |
| Parnax Lab | 1.46B |
| Aayush Wellness | 1.45B |
| Bilcare | 1.40B |
| Bal Pharma | 1.19B |
| Lactose (India) | 1.16B |
| Concord Drugs | 988.78M |